Rally In Celsion Continues On Upcoming HEAT Study Results And SPA Declaration By FDA
By Brian L. Wilson : We've seen a lot of exceptional performance in biotech stocks this year, especially in oncology drug development companies. One company that has been building significant momentum in recent trading is Celsion Corporation (NASDAQ: CLSN ) , which is developing a treatment for ...
Read the rest of this article on Long Investing Ideas from Seeking Alpha
Related Videos
-
Biotech and Pharma Still Look CheapDodge & Cox's Diana Strandberg and Charles Pohl discuss why the pharma industry looks like one of the most compelling places to invest today.